Loretta V.  Cangialosi net worth and biography

Loretta Cangialosi Biography and Net Worth

VP of Pfizer
Ms. Loretta V. Cangialosi has been a Senior Vice President and Controller of Pfizer, Inc since February 1993 and served as its Vice President. Ms. Cangialosi serves as a Member of Standing Advisory Group at Public Company Accounting Oversight Board (PCAOB).

What is Loretta V. Cangialosi's net worth?

The estimated net worth of Loretta V. Cangialosi is at least $2.84 million as of August 1st, 2018. Ms. Cangialosi owns 102,360 shares of Pfizer stock worth more than $2,843,561 as of March 28th. This net worth evaluation does not reflect any other investments that Ms. Cangialosi may own. Learn More about Loretta V. Cangialosi's net worth.

How do I contact Loretta V. Cangialosi?

The corporate mailing address for Ms. Cangialosi and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323. Learn More on Loretta V. Cangialosi's contact information.

Has Loretta V. Cangialosi been buying or selling shares of Pfizer?

Loretta V. Cangialosi has not been actively trading shares of Pfizer during the last quarter. Most recently, Loretta V. Cangialosi sold 26,814 shares of the business's stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $40.16, for a transaction totalling $1,076,850.24. Following the completion of the sale, the vice president now directly owns 102,360 shares of the company's stock, valued at $4,110,777.60. Learn More on Loretta V. Cangialosi's trading history.

Who are Pfizer's active insiders?

Pfizer's insider roster includes Ronald Blaylock (Director), Albert Bourla (DVM), Loretta Cangialosi (VP), William Carapezzi, Jr. (EVP), Albert D.V.M. (DVM), Frank Damelio (EVP), Frank D'Amelio (CFO & Exec. VP ), Jennifer Damico (SVP), Jennifer Damico (SVP), Scott Gottlieb (Director), Rady Johnson (Insider), Douglas Lankler (EVP), Alexander Mackenzie (EVP), Laurie Olson (Insider), Ian Read (CEO), Dawn Rogers (EVP), Sally Susman (Insider), and John Young (Insider). Learn More on Pfizer's active insiders.

Are insiders buying or selling shares of Pfizer?

In the last year, Pfizer insiders bought shares 3 times. They purchased a total of 5,000 shares worth more than $156,410.00. The most recent insider tranaction occured on December, 15th when Director Scott Gottlieb bought 3,000 shares worth more than $79,410.00. Insiders at Pfizer own 0.1% of the company. Learn More about insider trades at Pfizer.

Information on this page was last updated on 12/15/2023.

Loretta V. Cangialosi Insider Trading History at Pfizer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2018Sell26,814$40.16$1,076,850.24102,360View SEC Filing Icon  
5/24/2016Sell86,000$33.97$2,921,420.00271,663View SEC Filing Icon  
2/13/2015Sell104,000$34.73$3,611,920.00View SEC Filing Icon  
11/1/2013Sell10,000$31.20$312,000.00View SEC Filing Icon  
7/31/2013Sell14,688$29.63$435,205.44View SEC Filing Icon  
See Full Table

Loretta V. Cangialosi Buying and Selling Activity at Pfizer

This chart shows Loretta V Cangialosi's buying and selling at Pfizer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pfizer Company Overview

Pfizer logo
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More

Today's Range

Now: $27.78
Low: $27.54
High: $27.94

50 Day Range

MA: $27.47
Low: $25.89
High: $28.43

2 Week Range

Now: $27.78
Low: $25.61
High: $42.22

Volume

34,247,616 shs

Average Volume

47,501,112 shs

Market Capitalization

$157.31 billion

P/E Ratio

77.17

Dividend Yield

6.09%

Beta

0.61